Acquisition history Wasatch Infusion was acquired by Option Care Health in August 2018, indicating potential alignment with larger IV therapy networks and a readiness to partner with enterprise buyers or integrate into a broader patient care ecosystem.

Access to payer operations The company handles insurance preauthorizations in-house, suggesting a streamlined process and potential for offering bundled services or technology integrations that reduce administrative friction for partner clinics and hospital systems.

Premium patient experience Emphasis on comfort, safety, and patient amenities (recliners, streaming, WiFi, snacks, climate control) positions Wasatch Infusion as a luxury IV therapy provider, presenting upsell opportunities for premium infusion packages and wellness offerings to high-value patients and healthcare sponsors.

Strategic clinics footprint Multiple clinic locations with varied weekend closures (Murray open daily; St. George, Tooele, Layton limited schedules) indicate room for service expansion partnerships, co-location with primary care or specialty clinics, and regional enterprise sales roles.

Revenue scale & readiness Reported revenue range of 1M–10M and a recent history tied to an established health group suggest potential for scalable B2B partnerships, technology-enabled infusion management, or contract-based services with larger medical groups and ACOs.